KCNK15

KCNK15 (TASK-5) is a two-pore domain (K2P) potassium channel subunit that regulates neuronal excitability by acting as a modulatory partner of other TASK channels rather than as an autonomous conductance (PMID:39215006, PMID:39553828). As a homodimer it does not form functional K+ channels in heterologous systems, and this is not attributable to defective trafficking, since TASK-5 protein reaches the plasma membrane normally and removal of a putative ER retention sequence fails to restore activity; chimeric constructs show its intrinsic pore region is non-conducting (PMID:11749039, PMID:11409881, PMID:11680614). Instead, TASK-5 assembles into functional heterodimeric channels with TASK-1 and TASK-3, conferring altered single-channel conductance, altered Gq-coupled receptor-mediated inhibition, and changed sensitivity to TASK modulators, while also negatively modulating the surface expression of these channels (PMID:39215006). A common KCNK15 polymorphism alters the pharmacology of TASK-1/TASK-5 heterodimers, indicating that TASK-5 sequence variation shapes the drug-sensitivity profile of the heteromeric channel (PMID:39215006). In vivo, KCNK15 is expressed predominantly along the central auditory pathway, and Task5 knock-out mice show altered excitability of bushy cells of the ventral cochlear nucleus and principal neurons of the medial nucleus of the trapezoid body together with changed auditory brainstem responses, establishing a role in auditory processing (PMID:11749039, PMID:39553828).

1. 2001 High

   Whether TASK-5 forms a functional channel on its own was the first question; establishing that it does not redefined it from a candidate pore-former to a non-conducting subunit.

   Evidence Heterologous expression in Xenopus oocytes and COS-7 cells with TASK-5/TASK-3 chimeric channel electrophysiology

   PMID:11409881 PMID:11680614 PMID:11749039

   Open questions at the time

   • Did not test whether TASK-5 could function in heteromeric assemblies
   • Did not identify the structural basis of the non-conducting pore beyond the M1–M3 region
2. 2001 Medium

   To distinguish silence from mislocalization, it was important to learn whether the lack of current reflected a trafficking failure; demonstrating membrane localization placed the defect at the pore/assembly level.

   Evidence Subcellular localization in HEK293 cells with ER retention sequence deletion mutagenesis and electrophysiology

   PMID:11680614

   Open questions at the time

   • Single lab, single paper
   • Did not resolve why a membrane-localized subunit produces no current
   • Did not test heteromeric assembly partners
3. 2001 Medium

   Early heteromerization testing with TASK-1 (via a proton-insensitive H98N rescue assay) was needed to ask if TASK-5 could partner with other TASK subunits; the negative result initially argued against functional heteromers.

   Evidence Xenopus oocyte co-expression with TASK-1 H98N proton-sensitivity rescue assay

   PMID:11680614

   Open questions at the time

   • Single assay design later contradicted by single-channel work
   • Did not test TASK-3 as a partner
   • Proton-rescue readout may not detect all functional heteromers
4. 2001 Medium

   Defining the expression domain addressed where TASK-5 might act physiologically; its enrichment in the central auditory pathway pointed to a specialized role in auditory signal processing.

   Evidence In situ hybridization in rat brain

   PMID:11749039

   Open questions at the time

   • mRNA distribution without functional consequence tested at this stage
   • No protein-level confirmation in the auditory pathway
5. 2024 High

   The central question of whether TASK-5 has any channel function was resolved by showing it forms functional heterodimers with TASK-1 and TASK-3 that alter conductance, receptor regulation, pharmacology, and surface expression — reframing TASK-5 as an active modulatory subunit.

   Evidence Heterologous co-expression with single-channel electrophysiology, pharmacological characterization, and surface expression assays

   PMID:39215006

   Open questions at the time

   • Single rigorous study
   • Stoichiometry and structural interface of the heteromer not resolved
   • Mechanism by which TASK-5 lowers surface expression not defined
6. 2024 Medium

   Linking genetic variation to function, a common KCNK15 polymorphism was shown to alter TASK-1/TASK-5 heterodimer pharmacology, establishing that TASK-5 sequence shapes the drug response of the complex.

   Evidence Heterologous expression of polymorphic TASK-5 variants with electrophysiology and pharmacological probes

   PMID:39215006

   Open questions at the time

   • Single lab
   • Physiological or clinical impact of the polymorphism not established
   • Effect on TASK-3 heterodimers not tested
7. 2024 High

   An in vivo loss-of-function model was needed to confirm physiological relevance; Task5 knock-out mice with altered brainstem neuron excitability and auditory responses established TASK-5 as a functionally active K2P subunit in auditory processing.

   Evidence Task5 knock-out mice with whole-cell electrophysiology in brainstem neurons and auditory brainstem response recording

   PMID:39553828

   Open questions at the time

   • Did not define which TASK partner mediates the in vivo phenotype
   • Behavioral/hearing-threshold consequences beyond ABR not fully characterized

• The molecular determinants of how TASK-5 silences its own pore yet modulates TASK-1/TASK-3 conductance, surface expression, and pharmacology remain structurally undefined.
• No structure of TASK-5-containing heterodimers
• Heteromer stoichiometry and assembly determinants unknown
• Mechanism of negative regulation of TASK channel surface expression unresolved